Home / Resource Library / Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis

Study investigated long term outcomes of patients with diffuse large b-cell lymphoma treated with CAR-T therapy.